386 related articles for article (PubMed ID: 23473352)
1. Monoamine oxidase inhibitors revisited: what you should know.
Goldberg JF; Thase ME
J Clin Psychiatry; 2013 Feb; 74(2):189-91. PubMed ID: 23473352
[No Abstract] [Full Text] [Related]
2. Safety of high-intensity treatment with the irreversible monoamine oxidase inhibitor tranylcypromine in patients with treatment-resistant depression.
Adli M; Pilhatsch M; Bauer M; Köberle U; Ricken R; Janssen G; Ulrich S; Bschor T
Pharmacopsychiatry; 2008 Nov; 41(6):252-7. PubMed ID: 19067263
[TBL] [Abstract][Full Text] [Related]
3. Continuation and maintenance treatments in major depression: the neglected role of monoamine oxidase inhibitors.
Kennedy SH
J Psychiatry Neurosci; 1997 Mar; 22(2):127-31. PubMed ID: 9074307
[TBL] [Abstract][Full Text] [Related]
4. MAOIs in the contemporary treatment of depression.
Thase ME; Trivedi MH; Rush AJ
Neuropsychopharmacology; 1995 May; 12(3):185-219. PubMed ID: 7612154
[TBL] [Abstract][Full Text] [Related]
5. Classics in Chemical Neuroscience: Selegiline, Isocarboxazid, Phenelzine, and Tranylcypromine.
Hoffman GR; Olson MG; Schoffstall AM; Estévez RF; Van den Eynde V; Gillman PK; Stabio ME
ACS Chem Neurosci; 2023 Dec; 14(23):4064-4075. PubMed ID: 37966854
[TBL] [Abstract][Full Text] [Related]
6. Not all monoamine oxidase inhibitors are created equal.
Stewart JT
J Am Geriatr Soc; 2007 Nov; 55(11):1890. PubMed ID: 17979910
[No Abstract] [Full Text] [Related]
7. [Moclobemide].
Gleiter C; Volz HP
Dtsch Med Wochenschr; 1995 Aug; 120(34-35):1175-6. PubMed ID: 7656852
[No Abstract] [Full Text] [Related]
8. [The use of the monoamine oxidase inhibitor isocarboxazide in treatment-resistant depression].
Larsen JK; Krogh-Nielsen L; Brøsen K
Ugeskr Laeger; 2015 Dec; 177(52):V06150499. PubMed ID: 26692222
[TBL] [Abstract][Full Text] [Related]
9. [Monoamine oxidase inhibitors in psychiatry. Status of current knowledge].
Volz HP; Gleiter CH; Möller HJ
Nervenarzt; 1996 May; 67(5):339-47. PubMed ID: 9005342
[TBL] [Abstract][Full Text] [Related]
10. [Monoamine oxidase inhibitors as pharmaceutical agents].
Cherkes OI; Chekman IS
Farm Zh; 1969; 24(1):10-4. PubMed ID: 4389639
[No Abstract] [Full Text] [Related]
11. [Abuse of the monoamine oxidase (MAOI) inhibitors as antidepressive drugs: a critical review].
García-Campayo JJ; Sanz-Carrillo C; Ferrández Payo M
Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1995; 23(4):217-22. PubMed ID: 7484306
[TBL] [Abstract][Full Text] [Related]
12. [Classical monoamine oxidase inhibitor: not registered for, but still a place in the treatment of depression].
Nolen WA
Ned Tijdschr Geneeskd; 2003 Oct; 147(40):1940-3. PubMed ID: 14574774
[TBL] [Abstract][Full Text] [Related]
13. Psychopharmacology column: why choose selegiline transdermal system for refractory depression?
Tobin M
Issues Ment Health Nurs; 2007 Feb; 28(2):223-8. PubMed ID: 17365170
[No Abstract] [Full Text] [Related]
14. Monoamine oxidase-inhibiting antidepressants. A clinical update.
Murphy DL; Sunderland T; Cohen RM
Psychiatr Clin North Am; 1984 Sep; 7(3):549-62. PubMed ID: 6384960
[TBL] [Abstract][Full Text] [Related]
15. An operational evaluation of monoamine oxidase inhibitors.
Blackwell B; Taylor D
Proc R Soc Med; 1967 Aug; 60(8):830-4. PubMed ID: 6035423
[No Abstract] [Full Text] [Related]
16. MAO inhibition and antidepressant activity.
Feldstein A; Hoagland H; Rivera Oktem M; Freeman H
Int J Neuropsychiatry; 1965 Aug; 1(4):384-7. PubMed ID: 5324597
[No Abstract] [Full Text] [Related]
17. Combining tricyclic and monoamine oxidase inhibitor antidepressants.
Spiker DG; Pugh DD
Arch Gen Psychiatry; 1976 Jul; 33(7):828-30. PubMed ID: 942286
[TBL] [Abstract][Full Text] [Related]
18. Discussion: a fresh look at monoamine oxidase inhibitors for depression.
Cohen LJ; Sclar DA; Culpepper L; Flockhart DA; Hirschfeld RM; Thase ME; VanDenBerg CM
J Clin Psychiatry; 2012; 73 Suppl 1():42-5. PubMed ID: 22951242
[No Abstract] [Full Text] [Related]
19. Selegiline transdermal system in the prevention of relapse of major depressive disorder: a 52-week, double-blind, placebo-substitution, parallel-group clinical trial.
Amsterdam JD; Bodkin JA
J Clin Psychopharmacol; 2006 Dec; 26(6):579-86. PubMed ID: 17110814
[TBL] [Abstract][Full Text] [Related]
20. Selegiline transdermal system Somerset.
Mahmood I
Curr Opin Investig Drugs; 2002 Aug; 3(8):1230-3. PubMed ID: 12211421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
